Guillain-Barré Syndrome (GBS) is a rare neurological disorder that affects the nervous system, causing symptoms such as muscle weakness, numbness, tingling, loss of reflexes, and loss of sensation. While treatable, in some cases, it can have serious consequences, including long-term nerve damage, paralysis, and, rarely, death.

GBS typically affects 1 to 2 people per 100,000 in the general population and is slightly more common in men than in women. A history of illness such as childbirth, surgery, vaccination, upper respiratory tract infection, diarrhea, or gastroenteritis may occur 1 to 4 weeks before the onset of illness.

Although the exact cause of the disease is unknown, GBS occurs when the immune system attacks its own nervous system cells. It destroys the protective layer of nerves called myelin. This causes problems with nerve conduction and neurological symptoms that make it difficult to control the body.

In GBS patients, numbness typically begins symmetrically, usually in the extremities of the arms and legs. The numbness is usually followed by weakness and spreads over time. Symptoms such as difficulty swallowing and breathing may also occur during this time. The disease progresses rapidly and can reach its peak in approximately four weeks.

About half of GBS patients become unable to walk, and about a third may require respiratory support. There are several subtypes of GBS:

• AIDP (Acute Inflammatory Demyelinating Polyradiculoneuropathy): This is the classic form of GBS and accounts for approximately 90% of cases. Symmetrical symptoms begin primarily in the toes and legs. This subtype is usually triggered by an infection.
• AMAN (Acute motor axonal neuropathy): Occurs in 75% of GBS cases. It is associated with enteritis caused by the C. jejuni bacteria and can cause respiratory problems.
• AMSAN (Acute motor and sensory axonal neuropathy): Similar to AMAN but rarer. Motor and sensory nerve damage occurs and its course is usually rapid.
• MFS (Miller-Fisher Syndrome): Occurs after an upper respiratory tract infection. Recovery may take several weeks or months.

Untreated cases carry a risk of permanent nerve damage or death, with 6% to 17% of cases resulting in permanent damage or death. Current treatments may vary depending on the patient's clinical condition and symptoms. Different treatment options are evaluated based on the severity and duration of the disease. Early diagnosis and treatment are critical to reducing the effects of the disease. Therefore, prompt medical attention should be sought when symptoms appear.

What are the symptoms of GBS disease?

The symptoms of Guillain-Barré Syndrome (GBS) typically include a range of nervous system problems that can progress to muscle weakness and paralysis. The disease typically develops after an infection and presents with a range of nervous system symptoms. The central nervous system (brain and spinal cord) is not affected.

Symptoms of GBS may include:

• Tingling and numbness: Bilateral tingling, pins and needles, and numbness sensations in various parts of the body, such as the hands, arms, wrists, fingers, feet, ankles, and fingers.
• Sensory disturbances: Loss or alteration of sensations such as touch, pain, and temperature.
• Muscle weakness: Weakness and weakness felt especially in the hands, arms, legs, feet and other muscle groups.
• Difficulty in walking and moving: Difficulty in movements that are normally done easily, walking problems, difficulty climbing stairs.
• Sensory loss: Decreased or lost position sense in the arms and legs.
• Difficulty breathing: Difficulty breathing, difficulty taking deep breaths.
• Circulatory problems: Low or high blood pressure, heart rhythm disturbances.
• Other symptoms: Symptoms such as urination and retention problems, difficulty swallowing, and speech disorders may also be observed.

GBS symptoms typically progress rapidly and can sometimes lead to paralysis. These symptoms can reach their peak within a few weeks of the onset of the illness and then gradually subside. However, the course of symptoms can vary from case to case, and in some cases, treatment may be necessary. Common symptoms include weakness, loss of sensation, and incoordination. At the onset of illness or when symptoms are felt, immediate medical attention and consultation with a healthcare professional are essential.

What are the causes of GBS disease?

The exact cause of Guillain-Barré Syndrome (GBS) is unknown. However, it is generally thought to occur as a result of viral or bacterial infections in the body. Some factors that may trigger GBS include:

• Infections: GBS can occur following bacterial or viral infections, particularly Campylobacter jejuni (a bacterium commonly found in the intestines), Helicobacter pylori (a bacterium that causes stomach ulcers), and Mycoplasma pneumoniae (a bacterium that causes respiratory infections). These infections can stimulate the body's immune system, leading to a reaction that can lead to GBS.
• Vaccination: In very rare cases, GBS can develop after vaccination. It has been linked to certain vaccines, particularly the influenza vaccine. However, these cases are extremely rare.
• Genetic Predisposition: Genetic factors are thought to play a role in the development of GBS. However, this is still under investigation, and a clear link has not yet been established.

The nerve damage caused by GBS occurs when the body's own immune system mistakenly attacks it. This disease can damage the myelin sheath surrounding the nerves, as well as the nerves themselves. This can lead to impaired nerve conduction and muscle weakness. GBS usually has a sudden onset, and symptoms can progress rapidly. Therefore, if symptoms are felt, medical attention should be sought immediately.

How is GBS disease diagnosed?

Various methods and tests are used to diagnose Guillain-Barré Syndrome (GBS). The diagnostic process typically includes the following steps:

• Hospital examination and history taking: The patient's symptoms and history are thoroughly reviewed by a neurologist or specialist. The timing of the onset of symptoms, their severity, prevalence, and any association with other illnesses or infections are assessed.
• Physical and neurological examination: Physical examination and neurological tests are performed to evaluate symptoms such as muscle strength, reflexes, sensation, and muscle coordination.
• Laboratory tests: Laboratory tests, such as blood and urine tests, can help identify symptoms and possible causes of the disease. For example, tests for antibodies to infections may be done to determine if an infection specifically triggered GBS.
• Electromyography (EMG): An EMG is used to evaluate symptoms such as nerve damage or muscle weakness by measuring the electrical activity of nerves and muscles. This test can help identify conduction problems in the nerves.
• Lumbar puncture (cerebrospinal fluid test): This test examines cerebrospinal fluid, taken from the spinal cord area with a small needle. The fluid is examined for characteristics such as protein levels and white blood cell counts, which are used to support a GBS diagnosis.

Following all these tests and examinations, a neurologist or specialist can diagnose GBS based on the patient's symptoms, signs, and test results. Once diagnosed, an appropriate treatment and follow-up plan is determined. Early diagnosis and intervention are crucial to mitigate the effects of the disease and guide the treatment process.

What are the treatment methods for GBS disease?

Treatment for Guillain-Barré Syndrome (GBS) generally depends on the severity of symptoms, the stage of the disease, and the patient's condition. Treatment may include the following:

• Intensive care and respiratory support: Respiratory problems may occur in the advanced stages of GBS. In these cases, patients are monitored in the intensive care unit, and respiratory support devices may be used if necessary.
• Plasmapheresis (Plasma exchange): This treatment method involves removing some of the patient's blood and clearing the plasma of harmful antibodies. This removes autoantibodies that damage nerve cells from the body.
• Intravenous immunoglobulin (IVIG) therapy: Antibodies obtained from the healthy immune system are administered to the patient intravenously to prevent autoantibodies from damaging nerve cells.
• Physical therapy and rehabilitation: Physical therapy programs are implemented during or after recovery to address muscle weakness, limited mobility, or other physical difficulties. These programs aim to restore muscle strength and increase independence in daily activities.

Treatment of GBS may require a multidisciplinary approach and may vary for each patient. Early diagnosis and treatment can positively impact the course and outcome of the disease. Post-treatment follow-up and rehabilitation are important to improve the patient's quality of life.

What are the risk factors for Guillain-Barré Syndrome?

Risk factors for Guillain-Barré Syndrome include:

• Campylobacter jejuni: This bacterium is one of the infections that precedes the onset of disease in the majority of GBS patients.
• Viral infections: Viral infections such as Cytomegalovirus (CMV), Epstein Barr Virus (EBV), Haemophilus influenza virus, Mycoplasma pneumonia, HIV and Herpesvirus can trigger GBS.
• Hepatitis viruses: Hepatitis A, B, C, and E viruses may also increase the risk of GBS.
• Vaccines: The risk of GBS, particularly associated with influenza, rabies, and tetanus vaccines, is very low. However, if GBS develops after vaccination, re-administration of the same vaccine should be avoided.
• Surgical interventions: In some cases, surgical interventions can lead to GBS.
• Certain medications: The use of certain medications may also increase the risk of GBS.
• Coronavirus infection and vaccines: COVID-19 disease or COVID-19 vaccines may also increase the risk of GBS in rare cases. However, it's important to understand that this risk is quite low compared to other health risks arising from the disease itself.

In summary, it is known that factors such as multiple infections, certain viral diseases, vaccines, surgical interventions, and certain medications may play a role in the development of GBS. However, the likelihood of these factors increasing the risk of GBS is generally low.

Does Guillain-Barré syndrome go away on its own?

Guillain-Barré Syndrome is a disease that does not heal on its own. Patients' condition is often serious and can be life-threatening. Therefore, medical intervention is necessary, and hospital follow-up under medical supervision is essential. Early diagnosis and treatment are critical in preventing disease progression and the development of serious complications.

Is there an alternative method that can help Guillain-Barré syndrome?

Treatment for Guillain-Barré Syndrome generally includes effective immunological therapies (IVIG and plasmapheresis) and supportive therapies (respiratory support, physical therapy, etc.). However, there are no known effective alternative treatments. Therefore, medical intervention and medical supervision are the primary treatment options for GBS.